News
-
News
04 April 2019
The new NHS 10-year plan: What does it mean for ovarian cancer?
The NHS Long-Term Plan was published in early 2019. We take a look at some of the key ambitions and what they mean for ovarian cancer.
-
News
25 March 2019
New class of drugs could stop ovarian cancer cell growth
Researchers from The University of Manchester hope their findings could lead to new targeted treatment for ovarian cancer
-
News
13 March 2019
New cancer figures released for Northern Ireland
We take a look at how ovarian cancer diagnosis and survival in Northern Ireland has changed over the last few decades
-
News
12 March 2019
PARP inhibitors could boost the effects of immunotherapy in cancer patients
New research from the ICR found that the targeted drugs 'sparked a powerful immune response', which could open up new treatment possibilities
-
News
07 February 2019
Mars rover named after DNA pioneer Rosalind Franklin
Astronaut Tim Peake reveals that the new UK-made rover headed for Mars in 2020 will bear the name of British scientist Rosalind Franklin.
-
News
07 February 2019
First pilot scheme to map ovarian cancer care within the NHS in England
Charities team up to announce a joint project to map ovarian cancer care, surgery and survival across the NHS for the first time.
-
News
06 February 2019
New research suggests women may not need surgery for non-cancerous ovarian cysts
New research published in the journal Lancet Oncology has suggested women may not need to undergo surgery for non-cancerous ovarian cysts, avoiding potential surgical complications.
-
News
11 January 2019
Farewell to Professor Martin Gore: Leading cancer expert and former Director of the Ovarian Cancer Action Research Centre
We were deeply saddened to hear of the sudden death of Professor Martin Gore CBE
-
News
24 October 2018
New hope for women with BRCA mutated ovarian cancer
The results of an exciting new study offer hope to women with advanced stage, BRCA mutated ovarian cancer.
-
News
08 October 2018
Ovarian Cancer Action Research Grant Award Ceremony
Last night the Ovarian Cancer Action Research Grant Awards took place at the Royal Society, awarding funds to scientists working to tackle the disease at every level – from screening and early detection to treatment and recurrence.
-
News
20 September 2018
Cancer patients in Northern Ireland set to have same access to drugs as the rest of the UK
UPDATE: Women in Northern Ireland now have access to Niraparib, and the first patients in Northern Ireland have received the drug.
-
News
12 September 2018
Comment regarding potential urine test for ovarian cancer
Yesterday it was reported that a new urine test for ovarian cancer was on the horizon. We take a closer look at the story.
-
News
03 September 2018
Call for equal access to Niraparib for women in Northern Ireland
UPDATE: Women in Northern Ireland now have access to Niraparib, and the first patients in Northern Ireland have received the drug.
-
News
24 August 2018
Drug combination shows exciting results in ovarian cancer in early trial
A study published recently in the Annals of Oncology and reported by the Institute of Cancer Research has shown exciting results that could offer hope to thousands of women with recurrent, platinum-resistant advanced stage ovarian cancer.
-
News
23 August 2018
First ever NHS ovarian cancer early detection pilot announced
Ovarian Cancer Action is pleased to support the ALDO project; a pilot launched by The UCLH Cancer Collaborative, which aims to establish whether ovarian cancer screening can be feasible and cost effective on the NHS for women with BRCA1 and BRCA2 mutations.
-
News
13 August 2018
Exciting new research could lead to personalised ovarian cancer treatments
Patterns of genetic mutation in ovarian cancer are helping make sense of the disease and could be used to personalise treatment in future, according to a study published in Nature Genetics today.
-
News
10 August 2018
Innovative new treatment approved for Scottish ovarian cancer patients
The Scottish Medicine Consortium (SMC) has today approved a drug called Niraparib, providing new hope for women with...
-
News
26 July 2018
Could regular aspirin use reduce ovarian cancer risk?
There have been a series of reports recently claiming that taking aspirin can play a major role in both preventing ovarian cancer and increasing survival rates in women who already have the disease.
-
News
25 July 2018
10,000 signatures and counting — we did it!
Over the past few months, thousands of you have signed and shared the petition to the UK Government to fund a national clinical audit for ovarian cancer. Thanks to you, the petition has now reached 10,000 signatures, meaning we can expect a government response in due course.
-
News
10 July 2018
Allyson Kaye to step down as Chair after 13 years
After 13 years as Chair of Ovarian Cancer Action, Allyson Kaye MBE has announced her decision to step down. We are delighted that Allyson will continue her close connection with the charity in her new role of President, acting as an advisor and ambassador. Our current Vice-Chair, Dr Wayne Phillips has been appointed in her stead and Allyson will work closely with Wayne and the board as they embark on an exciting new chapter for the charity.